Page 86 - IngresoDr.MtzLanao

Langenbucher F, Mysicka J (1985). In vitro and in vivo deconvolution assessment of drug release
kinetics from oxprenolol Oros preparations. Br J Clin Pharmacol., (Suppl 2): 151S-162S.

Lee Y, Lee CH (2018). Augmented reality for personalized nanomedicines. Biotechnol Adv., 36(1):
335-343.

Leichner C, Jelkmann M, Bernkop-Schnürch A (2019). Thiolated polymers: Bioinspired polymers
utilizing one of the most important bridging structures in nature. Adv Drug Deliv Rev., 151-
152:191-221.

Levy G (1963). Effect of certain tablet formulation factors on dissolution rate of the active
ingredient I. Importance of using appropriate agitation intensities for in vitro dissolution rate
measurements to reflect in vivo conditions. J Pharm Sci., 52: 1039-46.

Lennernäs H, Lindahl A, Van Peer A, Ollier C, Flanagan T, Lionberger R, Nordmark A, Yamashita
S, Yu L, Amidon GL, Fischer V, Sjögren E, Zane P, McAllister M, Abrahamsson B (2017). In Vivo
Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of
Modern Approaches and Methodologies in a Regulatory Context. Mol Pharm., 14(4): 1307-1314.

Lennernäs H, Aarons L, Augustijns P, Beato S, Bolger M, Box K, Brewster M, Butler J, Dressman
J, Holm R, Julia Frank K, Kendall R, Langguth P, Sydor J, Lindahl A, McAllister M, Muenster U,
Müllertz A, Ojala K, Pepin X, Reppas C, Rostami-Hodjegan A, Verwei M, Weitschies W, Wilson C,
Karlsson C, Abrahamsson B (2014). Oral biopharmaceutics tools - time for a new initiative - an
introduction to the IMI project OrBiTo. Eur J Pharm Sci., 57: 292-299.

Levy G, Knox FG (1961). The biological activity of orally administered desicated thyroid. Am J
Pharm., 133: 255-256.

Levy G, Gumtow RH, Rutowski JM (1961). The effect of dosage form upon the gastrointestinal
absorption rate of salicylates. Can Med Assoc J., 85(8): 414-419.

Levy G, Antkowiak JM, Procknal JA, White DC (1963). Effects of certain tablet formulation factors
on dissolution rate of active ingredient II. Granule size strach concentration and compression
pressure. J Pharm Sci., 52: 1047-1051.

Levy G, Gangliardi BA (1963). Gastrointestinal absorption of aspirin anhydride. J Pharm Sci., 52:
730-732.

Lim, S.H., Kathuria, H., Tan, J.J.Y., Kang, L (2018). 3D printed drug delivery and testing systems
— a passing fad or the future? Advanced Drug Delivery Reviews., 132: 139–168.

Loisios-Konstantinidis I, Paraiso RLM, Fotaki N, McAllister M, Cristofoletti R, Dressman J (2019).
Application of the relationship between pharmacokinetics and pharmacodynamics in drug
development and therapeutic equivalence: a PEARRL review. J Pharm Pharmacol., 71(4): 699-
723.

Loo JCK, Riegelman S (1968). A new method for calculating the intrinsic absorption rate of drugs.
J Pharm Sci., 57: 918-928.

Lorenz B, Heesakkers H, Wölbeling C, Zimmer T (2018). “Pharma 4.0: Hype or Reality?”
Pharmaceut Engineer., 38(4): 40–44.

84